Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- recent history of immersion in spa water
- new medication commenced known to be associated with folliculitis
Otros factores de diagnóstico
- recent history of shaving
- umbilicated, flesh-coloured papules
- papules on one side of the face in the submaxillary area
- small, uniform papules and pustules
- background erythema
- alopecia/scalp scaling
- erythematous plaques with haemorrhagic crusts in a dermatomal distribution
Factores de riesgo
- trauma, including shaving and extraction
- topical corticosteroid preparations
- diabetes mellitus
- immunosuppression
- occlusion and perspiration
- systemic antibiotics
- immersion in under-chlorinated water
- drugs
Pruebas diagnósticas
Pruebas diagnósticas que deben considerarse
- bacterial skin swab
- viral skin swab
- skin scraping for mycology
- tissue culture
- skin biopsy
Algoritmo de tratamiento
uncomplicated superficial folliculitis, organism unknown
recurrent/deep folliculitis due to methicillin-susceptible Staphylococcus aureus (MSSA)
recurrent/deep folliculitis due to methicillin-resistant Staphylococcus aureus (MRSA)
gram-negative folliculitis
hot tub folliculitis due to Pseudomonas aeruginosa infection
dermatophytic folliculitis
Malassezia furfur (Pityrosporum folliculitis)
Candida folliculitis
HSV folliculitis
Demodex folliculorum folliculitis
drug-induced folliculitis
eosinophilic pustular folliculitis (Ofuji disease)
HIV-associated eosinophilic folliculitis
eosinophilic pustular folliculitis in infancy
Colaboradores
Autores
Joshua Hekmatjah, BS
Clinical Research Fellow
Dermatology Department
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Divulgaciones
JH declares that he has no competing interests.
Nazanin Ehsani-Chimeh, MD
Clinical Research Fellow
Dermatology Department
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Divulgaciones
NEC declares that she has no competing interests.
April W. Armstrong, MD, MPH
Associate Dean, Clinical Research
Associate Professor of Dermatology
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Divulgaciones
AWA has served as an investigator for Abbvie, Bristol-Myers-Squibb, Dermavent, Janssen, Eli Lilly, Modernizing Medicine, Novartis, OrthoDermalogics, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, and Sun Pharma; has been a speaker for Abbvie, Regeneron, and Sanofi Genzyme; and is a member of the data safety monitoring board for Boehringer Ingelheim/Paraxel. Her institution has received funding from Bristol-Myers-Squibb, Dermavent, Dermira, Eli Lilly, Galderma, Janssen-Ortho, Kyowa Hakko Kirin, Leo Pharma, Pfizer, and UCB Pharma.
Agradecimientos
Joshua Hekmatjah, Dr Nazanin Ehsani-Chimeh, and Dr April W. Armstrong would like to gratefully acknowledge Professor Howard Baden, a previous contributor to this topic.
Divulgaciones
HB declares that he has no competing interests.
Revisores por pares
Lowell Goldsmith, MD
Professor of Dermatology
Dean Emeritus
School of Medicine and Dentistry
University of North Carolina
Chapel Hill
NC
Divulgaciones
LG is editor-in-chief and co-founder of Logicalimages, Inc, which has print and electronic products for education and point-of-care; he has stock and stock options in that corporation. He is on the clinical and scientific advisory boards of Anacor Inc, which is developing anti-inflammatory and anti-infective products that are in early clinical trials; he receives payments and stock options for those services.
Dedee F. Murrell, MA, BMBCh, FAAD, MD
Head of Department
Department of Dermatology
St George Hospital
Conjoint Professor
University of New South Wales
Sydney
Australia
Divulgaciones
DFM declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Lucky AW, Esterly NB, Heskel N, et al. Eosinophilic pustular folliculitis in infancy. Pediatric Dermatol. 1984 Jan;1(3):202-6. Resumen
Buckley DA, Munn SE, Higgins EM. Neonatal eosinophilic pustular folliculitis. Clinical Exp Dermatol. 2001 May;26(3):251-5. Resumen
Faergemann J. Pityrosporum infections. J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S18-20. Resumen
Ota T, Hata A, Tanikawa A, et al. Eosinophilic pustular folliculitis (Ofuji's disease): indomethacin as a first choice of treatment. Clin Exp Dermatol. 2001 Mar;26(2):179-81. Resumen
Oranje AP, Folkers E. The Tzanck smear: old, but still of inestimable value. Pediatr Dermatol. 1988 May;5(2):127-9. Resumen
Ranki A, Hyry H, Klimenko T, et al. Update on current care guidelines. Bacterial skin infections [in Finnish]. Duodecim. 2010;126(24):2883-4. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diagnósticos diferenciais
- Pseudofolliculitis barbae
- Acne vulgaris
- Acne rosacea
Mais Diagnósticos diferenciais
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal